Innovation in Pediatric Drugs Act of 2023

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 6664 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 6664 To encourage innovation in the development of pediatric drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES December 7, 2023 Ms. Eshoo (for herself and Mr. McCaul) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To encourage innovation in the development of pediatric drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Innovation in Pediatric Drugs Act of 2023''. SEC. 2. PEDIATRIC STUDIES OF ORPHAN DRUGS. (a) Application of Pediatric Research Requirements to Orphan Drugs.-- (1) In general.--Section 505B of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355c) is amended by striking subsection (k). (2) Applicability.--The amendment made by paragraph (1) applies only to a…